AIS: Stock Quote & Summary Data |
Company Description (as filed with the SEC)
This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. You should not place undue reliance on those statements because they are subject to numerous uncertainties and factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control. You can identify these statements by the fact that they do not relate strictly to historical or current facts. ... More ...
Links to all Antares Pharma, Inc. (AIS) Pages
Stock Analysis
Fundamentals
Holdings
/Ownership
Consensus Recommendation |
|
Analyst Info |
|
| Annual EPS Est: | $-0.05 |
| Quarterly EPS Est: | -0.02 |
| PEG Ratio: | -.10 |
| Mean Recommendation: View Summary/View All |
1.5 |
Data is provided by Zacks Investment Research
Home
Search NASDAQ
Search Web

Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
